Phase 0 trials: a platform for drug development?

Abstract

Clearly, earlier identification of these drugs would increase the efficiency of drug development, allowing researchers to prioritise successful drugs, not only making effective drugs available to patients sooner, but also saving money-an appealing prospect for a troubled pharmaceutical industry.